MedMira Inc.
Description MedMira Inc., a biotechnology company, engages in the research, development, manufacture, and sale of rapid diagnostics and technology platforms. Its products include Reveal HIV, which detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal HP/MedMira Rapid H. Pylori antibody tests that detect Helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection; Reveal TP, a rapid syphilis antibody test, which detects treponema pallidum (TP) antibodies; Multiplo, a line of multiplex tests that combines testing solutions for HIV-1/2, Hepatitis B and C, and Syphilis in whole blood, serum, or plasma; and Miriad developer toolkit that facilitates the development and commercialization of rapid diagnostics. The company sells and distributes its products primarily in North America, Latin America/Caribbean, Europe, and the Asia Pacific. MedMira Inc. has collaborations with National Research Council of Canada, Traumatic Hemostasis and Oxygenation Research Network, and Kenya AIDS Vaccine Initiative. The company was founded in 1994 and is headquartered in Halifax, Canada. MedMira Inc. operates as a subsidiary of Onsite Lab Holding AG. To view the detailed information, you need to SUBSCRIBE with us. |
 |